Do you want to volunteer for Clinical Trials? Register now

Volunteer for Clinical Trials

Have you ever thought about taking part in a Medical Trial? By registering your details with, we are able to send your details directly to companies who are looking for volunteers to take part in their medical research studies.

Information about you is kept on a register that CROs, Pharmaceutical companies and Clinical Investigators can access to contact you regarding individual studies.

Register now >

Clinical Trials and Medical Trials is a website that will put you in direct contact with Pharmaceutical Companies, CRO’s (Clinical Research Organisations) and Clinical Investigators that are running Phase I (1) and Phase II (2) clinical trials.

Medical trials are an integral part of the drug development process. Patient and volunteer participation is vital for continued medical research and these trials are carried out under strict regulations.

Register as a Clinical Trial volunteer.

View information about current Clinical Trials.

If at any point you feel that you have changed your mind and are no longer interested in undertaking a medical trial you can unsubscribe from our service. If you are already part way through a medical trial, speak to the Clinical Investigator and they will advise you of your options.

Clinical research companies often offer financial compensation for your time and expenses.

Clinical Trial Information

Register now for clinical trials


Love may be the cure for drunkenness

Oxytocin is a hormone that plays a role in social and sexual behavior. Now, in a rat study, researchers have found that oxytocin also appears to prevent alcohol intoxication. Go to Source

more >

ESPERITE (Euronext ESP) pioneers first treatment worldwide of Cerebral Palsy using two types of stem cells

The clinical trial aims to demonstrate safety and preliminary efficacy of sequential intravenous infusion of the ex vivo expanded mesenchymal stem cells (MSC) derived from cord tissue and the cord… Go to Source

more >

Baricitinib superior to placebo in reducing rheumatoid arthritis disease activity in second Phase 3 study

Eli Lilly and Company and Incyte Corporation have announced that the investigational medicine baricitinib demonstrated a statistically significant improvement compared to placebo in a second… Go to Source

more >

Inflectra (infliximab) patient registry reports interim results in the treatment of inflammatory bowel disease

Data have been presented today on the use of Hospira’s Inflectra (infliximab), the world’s first approved biosimilar monoclonal antibody (mAb), at the European Crohn’s and Colitis Organisation… Go to Source

more >

Development of personalized cellular therapy for brain cancer

Preclinical study results pave the way for newly opened clinical trial of immune cells engineered to attack protein found on tumors in 30 percent of patients with glioblastomaImmune cells… Go to Source

more >

‘Precision medicine’ model may help prevent diabetes in at-risk population

New research published in The BMJ details the development of a ‘precision medicine’ model that could predict the best ways to prevent diabetes in those at high risk. Go to Source

more >